Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Tests The Waters: Prempro “Pilot” DTC Ad Planned For Fall

Executive Summary

Wyeth will test a new direct-to-consumer ad campaign for Prempro this fall to determine whether consumer advertising will encourage women to return to hormone replacement therapy

You may also be interested in...



Prempro DTC Campaign Touts Lowest Approved Dose Of Hormone Therapy

Wyeth's direct-to-consumer advertising campaign for Prempro highlights the hormone replacement therapy's lowest dose approved by FDA

Prempro DTC Campaign Touts Lowest Approved Dose Of Hormone Therapy

Wyeth's direct-to-consumer advertising campaign for Prempro highlights the hormone replacement therapy's lowest dose approved by FDA

Premarin Family Sales Stabilize, Wyeth Says; Price Increases Help

Premarin family sales have leveled off since the sharp decline seen in the months following the release of the Women's Health Initiative study, Wyeth reports

Related Content

UsernamePublicRestriction

Register

PS042512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel